These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 5519639)
21. ["Nil nocere." Side effects during treatment of Parkinson's disease with amantadine]. Diehl LW Munch Med Wochenschr; 1972 Mar; 114(10):445-7. PubMed ID: 4625982 [No Abstract] [Full Text] [Related]
22. [Treatment of the Parkinson syndrome with amantadine]. Hartmann-von Monakow K Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093 [No Abstract] [Full Text] [Related]
23. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Schneider E; Fischer PA; Jacobi P Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456 [No Abstract] [Full Text] [Related]
25. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes]. Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408 [No Abstract] [Full Text] [Related]
26. [Medical treatment of Parkinson's disease with amantadine hydrochloride. Preliminary note]. Portera A; Varela de Seijas E; Mata P; Ramírez Echevarría TJ; Amaya Pombo C Rev Clin Esp; 1970 Jun; 117(6):579-86. PubMed ID: 5518942 [No Abstract] [Full Text] [Related]
27. [Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months]. Campanella G; Zallone E; Buscaino GA Acta Neurol (Napoli); 1972; 27(5):491-500. PubMed ID: 4564842 [No Abstract] [Full Text] [Related]
28. [Amantadine in Parkinson's disease]. Streifler M; Kallay U Harefuah; 1972 Jun; 82(11):499-503. PubMed ID: 5068899 [No Abstract] [Full Text] [Related]
29. [Amantadine and dexetimide in the treatment of parkinsonism]. Hakkarainen H; Viukari M Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970 [No Abstract] [Full Text] [Related]
30. Plasma amantadine concentrations in patients with Parkinson's disease. Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813 [TBL] [Abstract][Full Text] [Related]
31. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism]. Man'kovskii NB; Vainshtok AB; Oleinik LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407 [No Abstract] [Full Text] [Related]
32. Amantadine in the treatment of Parkinson's disease. Schwab RS; England AC; Poskanzer DC; Young RR JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715 [No Abstract] [Full Text] [Related]
33. Renaissance of amantadine in the treatment of Parkinson's disease. Blanchet PJ; Metman LV; Chase TN Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683 [No Abstract] [Full Text] [Related]
34. [Amantadine in the treatment of Parkinson's disease]. Penders C Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353 [No Abstract] [Full Text] [Related]
35. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride]. Scotti G Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553 [No Abstract] [Full Text] [Related]
36. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"]. Völler G Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022 [No Abstract] [Full Text] [Related]
37. [Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease]. Beani L; Bianchi C; Gomirato G; Perfetti C; Cartei M Minerva Med; 1971 Oct; 62(82):3948-51. PubMed ID: 5125048 [No Abstract] [Full Text] [Related]